• Profile
Close

Multimorbidity in antineutrophil cytoplasmic antibody–associated vasculitis: Results from a longitudinal, multicenter data linkage study

Arthritis & Rheumatology Mar 12, 2021

Sarica SH, Gallacher PJ, Dhaun N, et al. - Researchers analyzed temporal trends in multimorbidity as well as excess health care costs related to multimorbidities in a national antineutrophil cytoplasmic antibody–associated vasculitis (AAV) cohort from Scotland. They matched 543 patients with AAV (median age 58.7 years; 53.6% men) and 2,672 general population controls (median age 58.7 years; 53.7% men) and observed them for a median of 5.1 years. A greater probability of experiencing individual morbidities at all time points, but specifically < 2 years post-diagnosis, was observed in AAV patients. Following 10 years, multimorbidity was present in 37.0% of AAV patients and 17.3% of controls. Multimorbidity was found to be related to disproportionate increments in health care costs in AAV patients. Overall, these data not only highlight that holistic care holds importance in AAV cases but also may identify a potentially critical opportunity to consider early screening.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay